Literature DB >> 33920328

PHB/CHIT Scaffold as a Promising Biopolymer in the Treatment of Osteochondral Defects-An Experimental Animal Study.

Eva Petrovova1, Marek Tomco2, Katarina Holovska1, Jan Danko1, Lenka Kresakova1, Katarina Vdoviakova1, Veronika Simaiova1, Filip Kolvek3, Petra Hornakova3, Teodor Toth4, Jozef Zivcak4, Peter Gal5,6,7, David Sedmera8,9, Lenka Luptakova10, Lubomir Medvecky1,11.   

Abstract

Biopolymer composites allow the creation of an optimal environment for the regeneration of chondral and osteochondral defects of articular cartilage, where natural regeneration potential is limited. In this experimental study, we used the sheep animal model for the creation of knee cartilage defects. In the medial part of the trochlea and on the medial condyle of the femur, we created artificial defects (6 × 3 mm2) with microfractures. In four experimental sheep, both defects were subsequently filled with the porous acellular polyhydroxybutyrate/chitosan (PHB/CHIT)-based implant. Two sheep had untreated defects. We evaluated the quality of the newly formed tissue in the femoral trochlea defect site using imaging (X-ray, Computer Tomography (CT), Magnetic Resonance Imaging (MRI)), macroscopic, and histological methods. Macroscopically, the surface of the treated regenerate corresponded to the niveau of the surrounding cartilage. X-ray examination 6 months after the implantation confirmed the restoration of the contour in the subchondral calcified layer and the advanced rate of bone tissue integration. The CT scan revealed a low regenerative potential in the bone zone of the defect compared to the cartilage zone. The percentage change in cartilage density at the defect site was not significantly different to the reference area (0.06-6.4%). MRI examination revealed that the healing osteochondral defect was comparable to the intact cartilage signal on the surface of the defect. Hyaline-like cartilage was observed in most of the treated animals, except for one, where the defect was repaired with fibrocartilage. Thus, the acellular, chitosan-based biomaterial is a promising biopolymer composite for the treatment of chondral and osteochondral defects of traumatic character. It has potential for further clinical testing in the orthopedic field, primarily with the combination of supporting factors.

Entities:  

Keywords:  biopolymer; cartilage; chitosan; regeneration; sheep model

Year:  2021        PMID: 33920328     DOI: 10.3390/polym13081232

Source DB:  PubMed          Journal:  Polymers (Basel)        ISSN: 2073-4360            Impact factor:   4.329


  5 in total

Review 1.  Biomechanical Aspects of Osteochondral Regeneration: Implications and Strategies for Three-Dimensional Bioprinting.

Authors:  Robert Choe; Eoin Devoy; Erfan Jabari; Jonathan D Packer; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2021-11-02       Impact factor: 7.376

2.  Vascular injury of immature epiphyses impair stem cell engraftment in cartilage defects.

Authors:  Ali Rashidi; Ashok J Theruvath; Ching-Hsin Huang; Wei Wu; Elhussein E Mahmoud; Joe Gerald Jesu Raj; Krzysztof Marycz; Heike E Daldrup-Link
Journal:  Sci Rep       Date:  2022-07-09       Impact factor: 4.996

Review 3.  Biomedical Applications of Polyhydroxyalkanoate in Tissue Engineering.

Authors:  Thiruchelvi Pulingam; Jimmy Nelson Appaturi; Thaigarajan Parumasivam; Azura Ahmad; Kumar Sudesh
Journal:  Polymers (Basel)       Date:  2022-05-24       Impact factor: 4.967

Review 4.  Roles of the calcified cartilage layer and its tissue engineering reconstruction in osteoarthritis treatment.

Authors:  Weiyang Wang; Ruixi Ye; Wenqing Xie; Yueyao Zhang; Senbo An; Yusheng Li; Yang Zhou
Journal:  Front Bioeng Biotechnol       Date:  2022-08-31

5.  Evaluation of Angiogenesis in an Acellular Porous Biomaterial Based on Polyhydroxybutyrate and Chitosan Using the Chicken Ex Ovo Chorioallantoic Membrane Model.

Authors:  Zuzana Demcisakova; Lenka Luptakova; Zuzana Tirpakova; Alena Kvasilova; Lubomir Medvecky; Ward De Spiegelaere; Eva Petrovova
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.